Livewire Ergogenics Trading Strength
Third Party Technical Analysis
|
|
Los Angeles, CA, April 17, 2018
- LiveWire Ergogenics, Inc. (OTC: LVVV), a company focused on the acquisition and licensing of special purpose real estate properties and management of legal, fully-controlled and self-contained turnkey production facilities for cannabis-based products and services receives extended coverage by three third party technical analysis services.
|
|
If you have followed our news, you have a good understanding about the progress at LiveWire. The Company has met several crucial development mile stones and continues to aggressively implement its business plan for 2018, further manifesting its position in the burgeoning California cannabis market.
As you know, we have added Livewire to our SWI Portfolio and are frequently reporting on the Company's progress. Today, we though it would be helpful to provide you with three important reports that provide technical analysis on LiveWire trading patterns, an unbiased third party opinion. Without any further comment:
|
|
For more information about LiveWire Ergogenics, visit
|
|
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the health and wellness industry. The Company is focused on acquiring and licensing specialized turnkey cannabis real estate locations and establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes the cloning of cannabis strains to produce positive medicinal results, dosing verification of zero pesticide products for quality brands via its “7X Pure” Cannabis Dosing and Verification System, and development and licensing of high-quality cannabinoid-based products and services. The team at LiveWire Ergogenics has a passion for research and is committed to generating and implementing innovative ideas and producing high-quality products that satisfy an increasing demand in this fast-growing industry.
INVESTOR CONTACT
EquiNet, LLC
Toll free: 877-964-6463
Direct: 858-264-6500
LIVEWIRE ERGOGENICS INC.
1600 North Kraemer Blvd.
Anaheim, CA 92806
714-740-5144
|
|
If you want to follow all other companies that we cover with more in depth research reports, go to our research site at
www.swiresearch.com/report-index
to download the reports,
Please feel free to re-distribute the reports to your friends and colleagues.
|
|
We initiated coverage of LiveWire Ergogenics on August 16, 2017
|
|
StockWatchIndex and SWI Research (SWI) are not registered investment advisers and the information provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI has been compensated with five million restricted shares (subject to the restrictions of rule 144) by the Company
for the dissemination of this and future releases and
for continuing consulting and advisory services. The included information is subject to change without notice. Please visit
www.swiresearch.com/#!legal-ease/lmvw1
for a full text of our Disclaimer, Privacy policy and Terms of Use.
|
|
|
|
|
|
|
